<!-- Clinical Trials Section -->
<div id="clinical-trials" class="content-section">
    <h2 class="section-title orange">Clinical Trials</h2>
    <div class="space-y">
        <div class="content-panel orange">
            <div class="panel-header">
                <div class="icon-circle orange">
                    <i class="fas fa-flask"></i>
                </div>
                <div>
                    <h3>Clinical Trial Information</h3>
                    <p>Understanding and finding clinical trials for LMS</p>
                </div>
            </div>
            <p class="panel-text">
                These videos provide information about clinical trials for Leiomyosarcoma, including how to find appropriate trials, what to expect, and how to determine if a trial is right for you.
            </p>
            <div class="videos-grid">
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/jVMw7irewYI" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/jVMw7irewYI/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">CH</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Candace Haddox</h5>
                            <p class="presenter-title">Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Phase 1 Clinical Trial Using Peposertib and Liposomal Doxorubicin</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> February 26, 2025</p>
                    <p class="video-description">Dr. Haddox discusses a novel Phase 1 clinical trial using Peposertib (M3814) and low-dose Liposomal Doxorubicin for metastatic Leiomyosarcoma and other soft tissue sarcomas.</p>
                    <a href="https://youtu.be/jVMw7irewYI" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/h4mi-aJT1tk" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/h4mi-aJT1tk/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">SP</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Seth Pollack</h5>
                            <p class="presenter-title">Lurie Cancer Center, Northwestern University, Chicago, IL</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Phase II Clinical Trial Using Zanzalintinib (XL092)</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> January 31, 2025</p>
                    <p class="video-description">Dr. Pollack discusses a Phase II clinical trial for Leiomyosarcoma patients using Zanzalintinib, a Tyrosine Kinase Inhibitor, currently enrolling at Northwestern University.</p>
                    <a href="https://youtu.be/h4mi-aJT1tk" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/EPeR4Wui3Bs" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/EPeR4Wui3Bs/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">JM</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. John Mullinax</h5>
                            <p class="presenter-title">Moffitt Cancer Center, Tampa, FL</p>
                        </div>
                    </div>
                    <h4 class="video-topic">STRASS 2/3 Clinical Trial for Retroperitoneal Leiomyosarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> January 2025</p>
                    <p class="video-description">Dr. Mullinax discusses the STRASS 2/3 clinical trial for the initial treatment of retroperitoneal Leiomyosarcoma and Liposarcoma.</p>
                    <a href="https://youtu.be/EPeR4Wui3Bs" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/kfOK0sNa4JQ" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/kfOK0sNa4JQ/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">VA</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Vishu Avutu</h5>
                            <p class="presenter-title">Memorial Sloan Kettering Cancer Center, New York, NY</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Phase 1a/2 Clinical Trial of GI-102 for Advanced Sarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> August 2024</p>
                    <p class="video-description">Dr. Avutu discusses a Phase 1a/2 clinical trial of GI-102, which boosts the immune system by blocking CTLA-4 and increasing immune cells via IL-2, for advanced sarcoma patients.</p>
                    <a href="https://youtu.be/kfOK0sNa4JQ" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/ioL0850rt7A" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/ioL0850rt7A/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">P</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Expert Panel</h5>
                            <p class="presenter-title">Multiple Institutions</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Clinical Trials Perspectives</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> February 2024</p>
                    <p class="video-description">A panel discussion by sarcoma medical oncologists on clinical trials for Leiomyosarcoma and other sarcomas.</p>
                    <a href="https://youtu.be/ioL0850rt7A" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/AU46FmcSc3Y" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/AU46FmcSc3Y/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">GC</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Gregory Cote</h5>
                            <p class="presenter-title">Massachusetts General Hospital, Boston, MA</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Lurbinectedin in Combination with Doxorubicin for Advanced Leiomyosarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> August 8, 2023</p>
                    <p class="video-description">Dr. Cote provides an overview of clinical trials and discusses his trial using Lurbinectedin with Doxorubicin for advanced Leiomyosarcoma.</p>
                    <a href="https://youtu.be/AU46FmcSc3Y" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://www.youtube.com/watch?v=ZHpMtNTwSRw" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/ZHpMtNTwSRw/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">BV</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Brian Van Tine</h5>
                            <p class="presenter-title">Siteman Cancer Center, Washington University, St. Louis, MO</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Cabozantinib with PD-1 and CTLA-4 Inhibition and Other Trials</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> July 20, 2023</p>
                    <p class="video-description">Dr. Van Tine discusses a Phase II trial of Cabozantinib with PD-1 and CTLA-4 inhibition and updates on three ongoing trials: Unesbulin, Pegylated Arginine Deiminase, and Olaparib with Temozolomide.</p>
                    <a href="https://www.youtube.com/watch?v=ZHpMtNTwSRw" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/V80SxCwx_cE" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/V80SxCwx_cE/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">BV</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Brian Van Tine</h5>
                            <p class="presenter-title">Siteman Cancer Center, Washington University, St. Louis, MO</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Updates on Three Promising Active LMS Clinical Trials</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> April 14, 2023</p>
                    <p class="video-description">Dr. Van Tine provides updates on three promising clinical trials for Leiomyosarcoma patients.</p>
                    <a href="https://youtu.be/V80SxCwx_cE" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/vArSCfUnAbM" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/vArSCfUnAbM/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">EN</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Elise Nassif</h5>
                            <p class="presenter-title">MD Anderson Cancer Center, Houston, TX</p>
                        </div>
                    </div>
                    <h4 class="video-topic">The Efficacy of Early-Phase Clinical Trials in Soft Tissue Sarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> September 21, 2022</p>
                    <p class="video-description">Dr. Nassif discusses the efficacy of early-phase clinical trials in soft tissue sarcomas, including Leiomyosarcoma.</p>
                    <a href="https://youtu.be/vArSCfUnAbM" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/HbwUvXcl7wg" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/HbwUvXcl7wg/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">BV</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Brian Van Tine</h5>
                            <p class="presenter-title">Siteman Cancer Center, Washington University, St. Louis, MO</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Unesbulin, New Treatment for Leiomyosarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> June 28, 2022</p>
                    <p class="video-description">Dr. Van Tine discusses Unesbulin (PTC596) as a new treatment for Leiomyosarcoma in an upcoming clinical trial.</p>
                    <a href="https://youtu.be/HbwUvXcl7wg" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/mY2q7q5VOlA" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/mY2q7q5VOlA/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">MI</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Matthew Ingham</h5>
                            <p class="presenter-title">Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY</p>
                        </div>
                    </div>
                    <h4 class="video-topic">New Treatment Approaches for LMS in Preclinical or Clinical Trials</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> June 8, 2022</p>
                    <p class="video-description">Dr. Ingham discusses new treatment approaches for Leiomyosarcoma in preclinical and clinical trials, including ATX-101 and Olaparib with Temozolomide.</p>
                    <a href="https://youtu.be/mY2q7q5VOlA" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/62gyn3nt6Z8" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/62gyn3nt6Z8/mqdefault.jpg" alt="Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">GS</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Dr. Gary Schwartz</h5>
                            <p class="presenter-title">Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma</h4>
                    <p class="video-date"><i class="far fa-calendar"></i> August 24, 2022</p>
                    <p class="video-description">Dr. Schwartz discusses a Phase II clinical trial evaluating Olaparib and Temozolomide for advanced uterine Leiomyosarcoma, moving to Phase III.</p>
                    <a href="https://youtu.be/62gyn3nt6Z8" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
                <div class="video-card orange">
                    <div class="youtube-badge">YouTube Podcast</div>
                    <a href="https://youtu.be/VTgeCwbEmkY" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <div class="video-thumbnail">
                            <img src="https://img.youtube.com/vi/VTgeCwbEmkY/mqdefault.jpg" alt="Clinical Trials Discussion - Video Thumbnail">
                            <i class="fas fa-play-circle video-play-icon"></i>
                        </div>
                    </a>
                    <div class="presenter-info">
                        <div class="presenter-avatar orange">
                            <span class="presenter-initial orange">VM</span>
                        </div>
                        <div>
                            <h5 class="presenter-name orange">Varun Monga, MD</h5>
                            <p class="presenter-title">Sarcoma Medical Oncologist â€” UCSF, San Francisco, CA</p>
                        </div>
                    </div>
                    <h4 class="video-topic">Clinical Trials Discussion</h4>
                    <p class="video-description">Hosted by the NLMSF. Dr. Monga discusses clinical trials relevant to Leiomyosarcoma patients.</p>
                    <a href="https://youtu.be/VTgeCwbEmkY" target="_blank" rel="noopener noreferrer" class="video-link orange">
                        <i class="fas fa-play-circle"></i> Watch Podcast
                    </a>
                </div>
            </div>
        </div>
    </div>
</div>
